What is the role of procainamide and esmolol in the treatment of Wolff-Parkinson-White (WPW) syndrome?

Updated: Jan 08, 2017
  • Author: Christopher R Ellis, MD, FACC, FHRS; Chief Editor: Mikhael F El-Chami, MD  more...
  • Print
Answer

Procainamide and esmolol are available for use in resistant cases but should only be administered by physicians familiar with these medications. Verapamil should not be administered to patients younger than 1 year because of risk of severe hypotension, severe bradycardia, or heart failure in this population of patients; this drug has also been reported to accelerate the ventricular rate in AF, leading to rapid conduction that results in ventricular fibrillation (VF).


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!